Table 3.

Overview of the most important parameters of each patient in the group without hyperoxaluria.

Patient number	BMI (kg/m2)	Age at oxalate evaluation (months)	Etiology of SBS	Urinary oxalate (mmol/mol creatinine)	Creatinine (mg/dl)	eGFR (ml/min/1.73 m2)	Renal pathology	Remaining expected short bowel length (%)
15	18.16	42	NEC	19	0.35	92.83	None	na
16	13.8	71	Intestinal atresia, Gastroschisis	49	0.26	113.85	None	17
17	23.9	179	NEC	27	0.77	na	None	11
18	18.18	7	NEC	140	0.34	104.51	None	44
19	16.2	126	Volvulus	15	0.34	158.53	None	26
20	17.81	27	Intestinal atresia	69	0.24	na	None	17
21	16.8	12	NEC	155	0.3	na	None	16
22	15.07	60	NEC	54	0.33	77.48	NC	5
23	17.2	117	Volvulus	29	0.42	102.83	None	11
24	13.9	70	NEC	12	0.42	110.73	None	na
25	14.24	72	Intestinal atresia	51	0.31	140.57	None	na
26	20.7	186	Meckel's diverticula	5.5	0.72	90.83	None	10

NC, nephrocalcinosis.